Prognosis Research Strategy (PROGRESS) 3: prognostic model research

Steyerberg, Ewout W.; Moons, Karel G.M.; van der Windt, Danielle A.; Hayden, Jill A.; Perel, Pablo; Schroter, Sara; Riley, Richard D.; Hemingway, Harry; Altman, Douglas G.

Abstract

Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS series, the authors review how such models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples.

Citation

Steyerberg, E. W., Moons, K. G., van der Windt, D. A., Hayden, J. A., Perel, P., Schroter, S., …Altman, D. G. (2013). Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Medicine, e1001381 -?. https://doi.org/10.1371/journal.pmed.1001381

• Journal Article Type: Article
• Acceptance Date: Feb 5, 2013
• Publication Date: Feb 5, 2013
• Journal: PLoS Medicine
• Print ISSN: 1549-1277
• Publisher: Public Library of Science
• Pages: e1001381 -?
• DOI: https://doi.org/10.1371/journal.pmed.1001381
• Keywords: Research validity, Prognosis, Decision making, Biomarkers, Cost-effectiveness analysis, Forecasting, Brain damage, Myalgia
• Publisher URL: http://dx.doi.org/10.1371/journal.pmed.1001381
• PMID: 23393430